Derivation of Limbal Stem Cells from Human Adult Mesenchymal Stem Cells for the Treatment of Limbal Stem Cell Deficiency
International Journal of Molecular Sciences · 25.01.2023 · 24 (3) · 2350
DOI: 10.3390/ijms24032350 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 25.01.2023. Verfasst von Marta Cadenas-Martin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Cell Engineering Laboratory, La Paz University Hospital Health Research Institute, IdiPAZ, 28046 Madrid, Spain. Hauptthemen laut MEDLINE: Limbus Corneae, Mesenchymal Stem Cells. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation Domingo Martinez, Roche Farma SA, Stem Vision SL.
Abstract (Originalsprache)
Approximately 10 million individuals have blindness due to limbal stem cell (LSCs) deficiency, one of the most challenging problems in ophthalmology. To replenish the LSC pool, an autologous extraocular cell source is appropriate, thereby avoiding the risk of immune rejection, the need for immunosuppression and the risk of damaging the contralateral eye. In recent years, adipose-derived mesenchymal stem cells (ADSCs) have been a key element in ocular regenerative medicine. In this study, we developed a protocol for deriving human LSCs from ADSCs compatible with the standard carrier human amniotic membrane, helping provide a stem cell pool capable of maintaining proper corneal epithelial homeostasis. The best protocol included an ectodermal induction step by culturing ADSCs with media containing fetal bovine serum, transforming growth factor-β inhibitor SB-505124, Wnt inhibitor IWP-2 and FGF2 for 7 days, followed by an LSC induction step of culture in modified supplemental hormonal epithelial medium supplemented with pigment epithelium-derived factor and keratinocyte growth factor for 10 additional days. The optimal differentiation efficiency was achieved when cells were cultured in this manner over vitronectin coating, resulting in up to 50% double-positive αp63/BMI-1 cells. The results of this project will benefit patients with LSC deficiency, aiding the restoration of vision.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cell Engineering Laboratory, La Paz University Hospital Health Research Institute, IdiPAZ, 28046 Madrid, Spain.
- Ophthalmology Department, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute, 28034 Madrid, Spain.
Förderung
- Foundation Domingo Martinez
- Roche Farma SA
- Stem Vision SL
- European Social Fund Ministry of Education, Youth and Sports of the Community of Madrid
- Ministry of Education, Youth and Sports of the Community of Madrid and by the European Social Fund (Youth Employment Initiative (YEI)
Zitieren
APA
Cadenas-Martin, M., Arnalich-Montiel, F., & Miguel, M. P. (2023). Derivation of Limbal Stem Cells from Human Adult Mesenchymal Stem Cells for the Treatment of Limbal Stem Cell Deficiency. International Journal of Molecular Sciences, 24(3), 2350. https://doi.org/10.3390/ijms24032350
Vancouver
Cadenas-Martin M, Arnalich-Montiel F, Miguel MP. Derivation of Limbal Stem Cells from Human Adult Mesenchymal Stem Cells for the Treatment of Limbal Stem Cell Deficiency. International Journal of Molecular Sciences. 2023;24(3):2350. doi:10.3390/ijms24032350
BibTeX
@article{CadenasMartin2023,
author = {Cadenas-Martin, Marta and Arnalich-Montiel, Francisco and Miguel, Maria P De},
title = {Derivation of Limbal Stem Cells from Human Adult Mesenchymal Stem Cells for the Treatment of Limbal Stem Cell Deficiency},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {3},
pages = {2350},
doi = {10.3390/ijms24032350}
}
EUVIMED